Common Contracts
4 similar Warrant Agreement contracts by A.C.T. Holdings, Inc.
ADVANCED CELL TECHNOLOGY, INC. WARRANT AGREEMENTWarrant Agreement • May 23rd, 2005 • A.C.T. Holdings, Inc. • Pharmaceutical preparations
This Warrant Agreement certifies that Gunnar Engstrom (the “Holder”), is the owner of 100,000 warrants (subject to adjustment as provided herein), each of which represent the right to subscribe for and purchase from A.C.T. Holdings, Inc., a Nevada corporation (the “Company”), one share of the Company’s common stock, $.001 par value, (such common stock, including any stock into which it may be changed, reclassified or converted, is herein referred to as the “Common Stock”) (“Warrants”) at the purchase price of $0.25 per share (subject to adjustment as provided herein) (the “Exercise Price”).
ADVANCED CELL TECHNOLOGY, INC. WARRANT AGREEMENTWarrant Agreement • May 23rd, 2005 • A.C.T. Holdings, Inc. • Pharmaceutical preparations
This Warrant Agreement, dated as of (the “Effective Date”), certifies that (the “Holder”), is the owner of warrants (subject to adjustment as provided herein), each of which represent the right to subscribe for and purchase from Advanced Cell Technology, Inc., a Delaware corporation (the “Company”), one share of the Company’s common stock, $.001 par value, (such common stock, including any stock into which it may be changed, reclassified or converted, is herein referred to as the “Common Stock”) (“Warrants”) at the purchase price of $0.05 per share (subject to adjustment as provided herein) (the “Exercise Price”), which have been issued by the Company in exchange for the Holder’s .
ADVANCED CELL TECHNOLOGY, INC. WARRANT AGREEMENTWarrant Agreement • May 23rd, 2005 • A.C.T. Holdings, Inc. • Pharmaceutical preparations
This Warrant Agreement certifies that (the “Holder”), is the owner of warrants (subject to adjustment as provided herein), each of which represent the right to subscribe for and purchase from Advanced Cell Technology, Inc., a Delaware corporation (the “Company”), one share of the Company’s common stock, $.001 par value, (such common stock, including any stock into which it may be changed, reclassified or converted, is herein referred to as the “Common Stock”) (“Warrants”) at the purchase price of $1.27 per share (subject to adjustment as provided herein) (the “Exercise Price”).
ADVANCED CELL TECHNOLOGY, INC. WARRANT AGREEMENTWarrant Agreement • May 23rd, 2005 • A.C.T. Holdings, Inc. • Pharmaceutical preparations
This Warrant Agreement, dated as of December 13, 2004 (the “Effective Date”), certifies that (the “Holder”), is the owner of warrants (subject to adjustment as provided herein), each of which represent the right to subscribe for and purchase from Advanced Cell Technology, Inc., a Delaware corporation (the “Company”), one share of the Company’s common stock, $.001 par value, (such common stock, including any stock into which it may be changed, reclassified or converted, is herein referred to as the “Common Stock”) (“Warrants”) at the purchase price of $0.25 per share (subject to adjustment as provided herein) (the “Exercise Price”), which have been issued by the Company as compensation for consulting services provided by the Holder to the Company.
